Work

A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study

Year: 2017

Type: article

Study design: Clinical Trial

Source: Urologic Oncology Seminars and Original Investigations

DOI: 10.1016/j.urolonc.2016.11.005

Authors: Rahul Aggarwal, Alan Bryce, Charles J. Ryan, Andrea Harzstark, Christina Derleth, Won Kim, Terence Friedlander, Amy M. Lin, Tammy Rodvelt-Bagchi, Mallika Dhawan, Li Zhang, Mina Lee, Eric Siebeneck, Jeffrey Hough, Eric J. Small

Institutions: University of California, San Francisco, UCSF Helen Diller Family Comprehensive Cancer Center, Mayo Clinic in Arizona, Vanderbilt University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Sanofi

OpenAlex ID: W2584053445

FWCI: 2.034

Cites: 23

Cited by: 15

Related to: 10